1. Topical combination therapy with vitamin D3 and corticosteroid ointment for palmoplantar pustulosis: A prospective, randomized, left-right comparison study
- Author
-
Hiroshi Kawakami, Yuka Matsumoto, Namiko Abe, Mayuko Muro, Ryoji Tsuboi, and Yukari Okubo
- Subjects
Vitamin ,Adult ,Male ,medicine.medical_specialty ,Palmoplantar pustulosis ,Erythema ,Combination therapy ,medicine.drug_class ,Administration, Topical ,Hyperkeratosis ,Dermatology ,Ointments ,030207 dermatology & venereal diseases ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,Calcitriol ,Psoriasis ,medicine ,Humans ,Prospective Studies ,Glucocorticoids ,Aged ,030203 arthritis & rheumatology ,Skin Diseases, Vesiculobullous ,business.industry ,Middle Aged ,medicine.disease ,Regimen ,Treatment Outcome ,chemistry ,Corticosteroid ,Drug Therapy, Combination ,Female ,Dermatologic Agents ,medicine.symptom ,business - Abstract
Vitamin D3 ointment and corticosteroid ointment are both used for the treatment of palmoplantar pustulosis (PPP). However, to date there is no systematic study of the efficacy of combination therapy for the treatment of PPP.We compared the efficacy of a topical combination therapy with vitamin D3 and a topical corticosteroid with that of topical corticosteroid alone in the treatment of PPP.We evaluated left-right comparison study of the efficacy of a combination therapy consisting of maxacalcitol ointment and betamethasone butyrate propionate ointment (BBP), and monotherapy with BBP alone in 27 patients with PPP for 8 weeks.The improvement in the symptom (erythema, pustules/vesicles, hyperkeratosis/scales) scores was high for the combination therapy. In particular, the improvement rate for pustules/vesicles at week 8 after the combination therapy was significantly higher than for the monotherapy (p 0.05).This combination regimen demonstrated that not only topical corticosteroids, but also topical vitamin D3 ointment, is useful for the treatment of PPP.
- Published
- 2015